Enable Injections, Inc.

Congratulations to our own Tim Flaherty for being awarded the Cincinnati Business Courier 2024 C-Suite Award for Chief Financial Officer! Tim’s business acumen and forward thinking have helped Enable Injections to obtain millions of dollars of funding, secure state and local incentives, transition from a clinical-stage to commercial company, expand our manufacturing capabilities, and building relationships with investors, community members, and within the Enable team. https://bit.ly/4032mnC

At Enable Injections, our greatest asset is our dedicated team of employees. At our first-ever company luncheon this summer, our whole team gathered to hear inspiring stories from a patient and nurse who have first-hand experience using our enFuse technology. Join our mission to improve the patient experience while also enjoying a collaborative and innovative culture with competitive pay and full benefits package! We’re currently hiring for our Product Development, Quality, and Manufacturing teams. #cincinnatijobs #werehiring

Thank you to everyone who visited us at the 2024 Injectables Summit! We are honored to have the opportunity to share how the combination of Serina Therapeutics, Inc.'s SER-252 and Enable Injection’s enFuse technology may improve the lives of those living with Parkinson’s. Contact us to learn more about our innovative, large-volume, on-body drug delivery solution: https://lnkd.in/eKacC7Xp Visit Serina Therapeutics’ website for more information on their revolutionary drug development process: https://lnkd.in/gRk_yjyJ ?#InjectablesSummit #drugdelivery #enFuse #SerinaTherapeutics

Our Chief Financial Officer Tim Flaherty has been named a finalist for the Cincinnati Business Courier 2024 C-Suite Awards! This award honors top executives for their outstanding leadership and stellar performance at Greater Cincinnati businesses and nonprofits. Tim’s role as CFO has been an integral part of Enable’s growth and funding initiatives, as well as Enable’s commitment to adding jobs, resources, state-of-the-art manufacturing, incentives, internal controls and best practices.? We’re proud to be part of such a distinguished selection of finalists: https://lnkd.in/gtzVfuGR??

Join us in Boston, MA from October 1-3 for the 2024 Injectables Summit! We will be joining our most recent partner, Serina Therapeutics, Inc. at the exhibit. Don’t miss our joint presentation about the development of Serina’s SER-252 in combination with our enFuse technology, and how the dynamic duo could reduce discomfort and deliver a game-changing therapy in the treatment for patients with advanced Parkinson’s disease. #InjectablesSummit #enFuse #medicaldevices

We are excited to be exhibiting and presenting at PDA - Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference 2024 from October 22-23 in Phoenix. ? Be sure to catch our posters, presentations, and stop by Booth #302 for more information about our innovative delivery solution!? ? #PDA #drugdelivery?#enFuse #PDAups

“When comparing preferences between traditional syringe pumps and the enFuse, an overwhelming 97.78% of nurses in the full sample expressed a clear preference for enFuse for preparation and administration of 5-25 mL of drug product.” Learn more about nurse preferences in drug administration in the September edition of ONdrugDelivery:?https://bit.ly/3XTycS1 #enFuse #drugdelivery

We hope to see you at the 2024 Injectables Summit from October 1-3 in Boston, MA! Enable Injections CCO Matthew Huddleston and Serina Therapeutics, Inc. CDO Randall Moreadith, MD, PhD will be sharing information on how their teams are partnering together to provide life-changing therapeutics with comfortable and convenient delivery to those living with Parkinson’s Disease. Don’t miss their presentation, “Patient-enabled Therapy for Advanced Parkinson's Disease - A Case Study with Serina Therapeutics' SER-252?+ Enable Injections' enFuse Wearable Drug Delivery Platform” at 10:15AM on Wednesday, October 2. #InjectablesSummit #drugdelivery #enFuse

Exciting News: Today, Enable announced agreement with Sobi? to develop and distribute Aspaveli? in combination with enFuse? in Sobi territories. “The future availability of Aspaveli with Enable Injection’s enFuse technology, could offer more patients the opportunity to access a simplified treatment experience that allows for greater confidence and mobility,” said Mike Hooven, Enable Injection’s Chairman and CEO. View full article here: https://bit.ly/4elfrMN #enFuse #drugdelivery?

As a Cincinnati founded company, we’re proud to be a part of Cincinnati Museum Center’s Advancing Health exhibit! Our #enFuse technology is on display along with other locally developed medical technologies. This exhibit is the latest permanent addition to the museum and is now open to the public. Learn more: https://lnkd.in/gm_GuHFy